Schering-Plough Off-Label Marketing MDL Dunzo

Law360, New York (June 11, 2010, 4:44 PM EDT) -- A federal judge has dismissed with prejudice two class action complaints from consumers and third-party payors accusing Schering-Plough Corp. of improperly marketing drugs for off-label use, closing the book on litigation that has plagued the former pharma giant since 2006.

The consumer class lacked standing because lead plaintiff Angela Montgomery could not prove a nexus between the defendants’ actions and her alleged injury, while third-party payors failed to sufficiently plead Racketeer Influenced and Corrupt Organizations Act claims, Judge Stanley R. Chesler of the U.S. District Court...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.